{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:41:31Z","timestamp":1783395691952,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012643","name":"Edward Mallinckrodt, Jr. Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ijantimicag.2019.105864","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T11:28:57Z","timestamp":1576841337000},"page":"105864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro activity of meropenem\/piperacillin\/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp"],"prefix":"10.1016","volume":"55","author":[{"given":"Aki","family":"Yoneda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Th\u00e4nert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey-Ann D.","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ijantimicag.2019.105864_bib0001","first-page":"1970","article-title":"National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011","volume":"173","author":"Dantes","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.ijantimicag.2019.105864_bib0002","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: the example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.ijantimicag.2019.105864_bib0003","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nchembio.1911","article-title":"Synergistic, collaterally sensitive beta-lactam combinations suppress resistance in MRSA","volume":"11","author":"Gonzales","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ijantimicag.2019.105864_bib0004","series-title":"CLSI standard M07","article-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2018"},{"issue":"6","key":"10.1016\/j.ijantimicag.2019.105864_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02481-18","article-title":"Population structure, antibiotic resistance, and uropathogenicity of Klebsiella variicola","volume":"9","author":"Potter","year":"2018","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.ijantimicag.2019.105864_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00612-17","article-title":"SCCmecFinder, a web-based tool for typing of staphylococcal cassette chromosome mec in Staphylococcus aureus using whole-genome sequence data","volume":"3","author":"Kaya","year":"2018","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.ijantimicag.2019.105864_bib0007","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/AAC.42.3.717","article-title":"Analysis of diversity of mutations in the mecI gene and mecA promoter\/operator region of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis","volume":"42","author":"Kobayashi","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2019.105864_bib0008","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01788-17","article-title":"Epidemiology, clinical characteristics, and antimicrobial susceptibility profiles of human clinical isolates of Staphylococcus intermedius group","volume":"56","author":"Yarbrough","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"22","key":"10.1016\/j.ijantimicag.2019.105864_bib0009","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00018-005-5148-6","article-title":"Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome","volume":"62","author":"Fuda","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"10.1016\/j.ijantimicag.2019.105864_bib0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jiac.2018.03.004","article-title":"Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired MRSA","volume":"24","author":"Harada","year":"2018","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2019.105864_bib0011","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diagmicrobio.2017.04.016","article-title":"Continued expansion of USA300-like methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients in the United States","volume":"88","author":"Tickler","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ijantimicag.2019.105864_bib0012","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1128\/JB.01128-07","article-title":"Gene acquisition at the insertion site for SCCmec, the genomic island conferring methicillin resistance in Staphylococcus aureus","volume":"190","author":"Noto","year":"2008","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.ijantimicag.2019.105864_bib0013","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1086\/675283","article-title":"Continued emergence of USA300 methicillin-resistant Staphylococcus aureus in the United States: results from a nationwide surveillance study","volume":"35","author":"Diekema","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2019.105864_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nchembio.1205","article-title":"Systems-level antimicrobial drug and drug synergy discovery","volume":"9","author":"Roemer","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"15","key":"10.1016\/j.ijantimicag.2019.105864_bib0015","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ijantimicag.2019.105864_bib0016","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1016\/j.ijid.2012.12.013","article-title":"Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA","volume":"17","author":"Pasquale","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.ijantimicag.2019.105864_bib0017","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/jac\/dkw123","article-title":"Effect of bla regulators on the susceptible phenotype and phenotypic conversion for oxacillin-susceptible mecA-positive staphylococcal isolates","volume":"71","author":"Liu","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ijantimicag.2019.105864_bib0018","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.37.5.1144","article-title":"blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus","volume":"37","author":"Hackbarth","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.ijantimicag.2019.105864_bib0019","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1592\/phco.24.16.1641.50960","article-title":"Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy","volume":"24","author":"Kuti","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"10","key":"10.1016\/j.ijantimicag.2019.105864_bib0020","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41564-019-0471-0","article-title":"Genomic identification of cryptic susceptibility to penicillins and beta-lactamase inhibitors in methicillin-resistant Staphylococcus aureus","volume":"4","author":"Harrison","year":"2019","journal-title":"Nat Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:35:39Z","timestamp":1760376939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919303358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0924857919303358"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.105864","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of meropenem\/piperacillin\/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.105864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105864"}}